In a filing, Bristol-Myers Squibb Co revealed its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $0.11 million on Feb 20 ’25. In the deal valued at $55.05 per share,2,000 shares were bought. As a result of this transaction, BOERNER CHRISTOPHER S. now holds 104,626 shares worth roughly $5.01 million.
Then, Hirawat Samit bought 1,823 shares, generating $100,000 in total proceeds. Upon buying the shares at $54.84, the EVP,Chief Med.Offr.,Drug Dev. now owns 63,932 shares.
Before that, Holzer Phil M sold 700 shares. Bristol-Myers Squibb Co shares valued at $38,930 were divested by the SVP and Controller at a price of $55.62 per share. As a result of the transaction, Holzer Phil M now holds 11,760 shares, worth roughly $0.56 million.
Piper Sandler initiated its Bristol-Myers Squibb Co [BMY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. Jefferies also remained covering BMY and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of BMY
On Friday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock fall -1.62% to $47.90. Over the last five days, the stock has lost -2.70%. Bristol-Myers Squibb Co shares have fallen nearly -15.31% since the year began. Nevertheless, the stocks have fallen -2.22% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $39.35 was recorded on 04/24/25. SMA at 50 days reached $56.54, while 200 days put it at $53.86.
Levels Of Support And Resistance For BMY Stock
The 24-hour chart illustrates a support level at 46.92, which if violated will result in even more drops to 45.95. On the upside, there is a resistance level at 48.91. A further resistance level may holdings at 49.92. The Relative Strength Index (RSI) on the 14-day chart is 26.55, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.02%. Stochastics %K at 11.88% indicates the stock is a buying.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-04-15, dropping by -6.98 million shares to a total of 30.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 37.01 million shares. There was a decline of -23.23%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on November 15, 2024 when Wolfe Research began covering the stock and recommended ‘”a Peer perform”‘ rating .
